Concepedia
Journal of Pharmacology and Experimental Therapeutics · 2012 · 57 citations · 40 references
40
A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Aline Dumuis, Rochdi Bouhelal, Michèle Sebben et al. · Molecular Pharmacology · 1988 · 437 citations
Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery
J. Cory Kalvass, Tristan S. Maurer · Biopharmaceutics & Drug Disposition · 2002 · 413 citations
The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.
Christophe Gerald, Nika Adham, Hung‐Teh Kao et al. · The EMBO Journal · 1995 · 245 citations · Full text
Molecular Pharmacology, Molecular Physiology, Functional Selectivity +7
5‐Hydroxytryptamine (5‐HT)<sub>4</sub> receptors in <i>post mortem</i> human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases
Gavin P. Reynolds, Sarah Mason, A. Meldrum et al. · British Journal of Pharmacology · 1995 · 198 citations · Full text
Neurotransmitter, Hill Coefficients, Social Sciences +16
Novel Brain-Specific 5-HT4 Receptor Splice Variants Show Marked Constitutive Activity: Role of the C-Terminal Intracellular Domain
Sylvie Claeysen, Michèle Sebben, Carine Bécamel et al. · Molecular Pharmacology · 1999 · 185 citations